Login / Signup

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.

Simona PiemonteseF CiceriM LabopinW ArceseS Kyrcz-KrzemienS SantaroneH HuangD BeelenN C GorinC CraddockZ GulbasA BacigalupoM MohtyA Naglernull null
Published in: Journal of hematology & oncology (2017)
Patients with acute leukemia in remission have better outcomes if transplanted from a MUD 10/10. We did not find any significant difference in outcome between transplants from MMUD 9/10 and Haplo, suggesting that both can be equally used in the absence of a 10/10 MUD. KEY POINT 1: Better outcomes using fully (10/10) matched unrelated donor for allo-SCT in acute leukemia in remission. KEY POINT 2: Similar outcomes after allo-SCT from unmanipulated haploidentical graft or mismatched (9/10) unrelated donor in acute leukemia in remission.
Keyphrases
  • stem cell transplantation
  • high dose
  • disease activity
  • cord blood
  • ulcerative colitis
  • low dose
  • systemic lupus erythematosus
  • bone marrow
  • type diabetes
  • adipose tissue
  • insulin resistance
  • peripheral blood